Search the Newsreel

Pinnacle West SVP Jose Luis Esparza Jr sells $183,618 in stock

Jose Luis Esparza Jr., SVP Public Policy at APS (a subsidiary of Pinnacle West Capital Corp), sold 1,800 shares of the company's common stock for $183,618. Following this transaction, Esparza directly holds 4,910 shares. Pinnacle West Capital Corp. appears overvalued but offers an attractive …

Elizabeth Blankenship Sells 980 Shares of Pinnacle West Capital (NYSE:PNW) Stock

Elizabeth Blankenship, Chief Accounting Officer of Pinnacle West Capital (NYSE:PNW), sold 980 shares of the company's stock for approximately $97,187, reducing her ownership by 8.26%. This insider sale comes as the company reported quarterly EPS slightly below estimates but saw revenue increase by 7.1% …

Insider Selling: Pinnacle West Capital (NYSE:PNW) SVP Sells $183,618.00 in Stock

Pinnacle West Capital (NYSE:PNW) SVP Jose Luis Esparza Jr. sold 1,800 shares of the company's stock for $183,618.00 on August 7th, reducing his holdings by 26.83%. The sale follows the company's recent earnings report, where it missed EPS consensus but saw a 7.1% rise …

InnovAge Holding Corp (INNV) Shares Fall 6.4% -- What GF Score of 62 Tells Investors

InnovAge Holding Corp (INNV) shares dropped 6.4% to $10.23, indicating it is 55.9% overvalued according to GuruFocus's GF Value estimate. Despite a strong financial strength sub-rank of 7/10, its overall GF Score of 62/100 is dragged down by weak valuation (3/10) and momentum (3/10) …

FBIN: Strategic realignment targets faster innovation, cost savings, and improved service by year-end

FBIN Management has announced a strategic refocus to prioritize external customer needs, decentralize marketing, and accelerate product innovation. The company aims for $70 million in cost savings by year-end, expects service levels to normalize, and plans to allocate capital towards organic growth and shareholder …

Three Innoviva therapies named finalists for Prix Galien award

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., announced that three of its infectious disease therapies—XACDURO, ZEVTERA, and NUZOLVENCE—have been named finalists for the 2026 Prix Galien USA Award in the Best Pharmaceutical Product category. This marks the third consecutive year an Innoviva product …

Fortune Brands Innovations (FBIN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Vice President, Finance, and Investor Relations - Curt WorthingtonChief Executive Officer - Jesse SinghChief Operating Officer - David BarryInterim Chief Financial Officer - Ashley George TAKEAWAYS Net Sales …

Onto Innovation Jumps 7.5% After Needham Maintains Buy

Onto Innovation Inc. shares surged 7.5% to $313.29 after three Wall Street firms, including Needham, Evercore ISI Group, and Jefferies, upgraded their price targets, signaling increased confidence in the semiconductor equipment maker. Needham raised its target from $330 to $360, Evercore ISI Group from …

Foods & Inns Announces Resignation of Company Secretary and Compliance Officer

Foods & Inns CFO Anand Krishnan Steps Down After Managed Transition

Innventure Inc expected to post a loss of 25 cents a share - Earnings Preview

Innventure Inc is expected to report a loss of 25 cents per share, according to an earnings preview. The article indicates that full details are available to subscribers of TradingView, which aggregates news from various sources including Reuters.

Fortune Brands Innovations Inc. stock outperforms competitors on strong trading day

Fortune Brands Innovations Inc. (FBIN) saw its stock rise by 4.19% to $50.00 on Tuesday, outperforming the broader market as the S&P 500 and Dow Jones Industrial Average both declined. Despite the strong trading day, the company's stock remains 22.89% below its 52-week high.

SS Innovations International, Inc. expected to post a loss of 2 cents a share - Earnings Preview

SS Innovations International, Inc. is projected to report a loss of 2 cents per share, according to an earnings preview. The article indicates this financial expectation for the company.

PURPLE INNOVATION ($PRPL) Releases Q2 2026 Earnings

Aurora Innovation (AUR) director Volpi reports fund sales and large share gift

Aurora Innovation director Michelangelo Volpi reported that entities associated with him, Index Ventures Growth III and Yucca, sold 1,889,023 Class A shares following conversions from Class B shares on August 7 and 10, 2026, at weighted average prices of $7.0523 and $7.0004 per share. …

Earnings call transcript: Purple Innovation posts Q2 2026 miss as stock falls

Purple Innovation reported a wider-than-expected loss and lower-than-forecast revenue for Q2 2026, causing its stock to fall by a combined 16.7%. Despite the financial miss, the company highlighted improved gross margins, positive adjusted EBITDA, and strong showroom sales, driven by premium product performance. However, …

Innovative Aerosystems to Change Nasdaq Ticker Symbol to "IA" Following Corporate Rebranding

EXTON, Pa., August 11, 2026--(BUSINESS WIRE)--Innovative Aerosystems (Nasdaq: ISSC), a leading provider of advanced avionic solutions for commercial, business aviation and military markets, today announced that the Company will cease trading under the Nasdaq ticker symbol "ISSC" and begin trading under the symbol "IA" …

Foods & Inns Q1FY27 revenue drops 34% to ₹152.4 crore on export woes

Purple Innovation (PRPL) warns on going concern amid debt, improved cash flow

Innova Captab Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Foods & Inns Sets Record Date and Book Closure for 54th AGM and Dividend

Foods & Inns to set up F-HAD Private Limited for food branding push

Foods & Inns Q1 FY’27 Results Hit by Export Logistics Disruptions

Onto Innovation Inc Stock (ONTO) Moved Up by 7.27% on Aug 11: What Signal Does It Send?

Onto Innovation Inc. (ONTO) saw its stock rise by 7.27% on August 11, driven by strong fundamental performance and positive industry tailwinds in the semiconductor capital equipment sector. The company exceeded earnings expectations due to high demand for its inspection and metrology platforms, achieved …

Innova Captab Q1FY27 net profit rises 42% to ₹441.26 mn on revenue growth

Innate Pharma stock price target raised to $7 by H.C. Wainwright on Sobi deal

H.C. Wainwright has increased its price target for Innate Pharma (NASDAQ:IPHA) to $7.00 from $5.00, maintaining a Buy rating, following Innate Pharma's strategic partnership with Swedish Orphan Biovitrum for lacutamab. The deal, valued up to $465 million plus royalties, is expected to extend Innate …

Pinnacle West Capital (PNW) Q2 2026 Earnings Call Transcript

Pinnacle West Capital (PNW) reported Q2 2026 consolidated net income of $178.6 million and diluted EPS of $1.43, a decrease from the prior year due to higher interest charges and depreciation, despite an increase in total operating revenues to $1.46 billion. The company experienced …

Onto Innovation Jumps 6% Tuesday Following Camtek Earnings and NVIDIA’s $500 Billion Partnership

Quick Read Onto Innovation surged 6% Tuesday and is up 85% year to date, riding AI-driven demand for its HBM and advanced packaging inspection tools. Camtek's record $133 million quarter and $600 million in YTD bookings, plus NVIDIA's $500 billion AI infrastructure financing deal, …

Onto Innovation (NYSE:ONTO) Trading 7.5% Higher - Time to Buy?

Onto Innovation Inc. (ONTO) stock price, news, quote and history

Onto Innovation (ONTO) Upgraded to Strong Buy: Here's What You Should Know

Onto Innovation (ONTO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. …

Bannari Amman Spinning Mills reappoints MD, approves dividend at AGM

Insider Move: Jesse Singh Invests $2.02M In Fortune Brands Stock

Jesse Singh, CEO of Fortune Brands (NYSE: FBIN), recently made a significant insider purchase, investing $2.02 million in company stock. This transaction involved buying 39,285 shares and signals his confidence in the company, despite a reported revenue decline of 4.11% as of June 30, …

Innovex International (NYSE:INVX) Stock Price Expected to Rise, Barclays Analyst Says

Barclays has raised its price target for Innovex International (NYSE:INVX) to $27, though it maintained an "equal weight" rating, suggesting a potential downside. Despite this, other analysts have a "Moderate Buy" consensus with an average target of $32.50, following Innovex's strong quarterly earnings beat. …

How Earnings Beat, TCO Deal and Share Offering Will Impact Innovex International (INVX) Investors

Innovex International (INVX) recently announced strong Q2 2026 results, including increased sales and net income, alongside the acquisition of TCO Group AS and a share offering. These developments highlight the company's efforts to reshape its portfolio and capital structure. Investors should consider these positive …

Latham & Watkins Advises Summit Hotel Properties in US$200 Million At-the-Market Program

Latham & Watkins LLP advised Summit Hotel Properties, Inc. (NYSE: INN) in its US$200 million at-the-market equity program. The real estate investment trust will offer and sell shares of its common stock. A Latham & Watkins team led by partners Mollie Duckworth, Jonathan Sarna, …